242 related articles for article (PubMed ID: 35657562)
1. ATP-gated P2X7 receptor as a potential target for prostate cancer.
Qiao C; Tang Y; Li Q; Zhu X; Peng X; Zhao R
Hum Cell; 2022 Sep; 35(5):1346-1354. PubMed ID: 35657562
[TBL] [Abstract][Full Text] [Related]
2. P2X7 mediates ATP-driven invasiveness in prostate cancer cells.
Qiu Y; Li WH; Zhang HQ; Liu Y; Tian XX; Fang WG
PLoS One; 2014; 9(12):e114371. PubMed ID: 25486274
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.
Bai X; Li Q; Peng X; Li X; Qiao C; Tang Y; Zhao R
Purinergic Signal; 2023 Dec; 19(4):685-697. PubMed ID: 36854856
[TBL] [Abstract][Full Text] [Related]
4. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
5. Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma.
Li X; Bai X; Tang Y; Qiao C; Zhao R; Peng X
Chem Biol Drug Des; 2023 Mar; 101(3):794-808. PubMed ID: 36403102
[TBL] [Abstract][Full Text] [Related]
6. Purinergic P2X7R as a potential target for pancreatic cancer.
Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X
Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920
[TBL] [Abstract][Full Text] [Related]
7. P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death.
Bian S; Sun X; Bai A; Zhang C; Li L; Enjyoji K; Junger WG; Robson SC; Wu Y
PLoS One; 2013; 8(4):e60184. PubMed ID: 23565201
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Ghalali A; Wiklund F; Zheng H; Stenius U; Högberg J
Carcinogenesis; 2014 Jul; 35(7):1547-55. PubMed ID: 24451147
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor: a critical regulator and potential target for breast cancer.
Zhu X; Li Q; Song W; Peng X; Zhao R
J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
[TBL] [Abstract][Full Text] [Related]
11. Progress in the relationship between P2X7R and colorectal cancer.
Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
[TBL] [Abstract][Full Text] [Related]
12. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
14. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ
J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198
[TBL] [Abstract][Full Text] [Related]
15. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib.
Salahuddin MM; Omran GA; Helmy MW; Houssen ME
Curr Issues Mol Biol; 2021 Dec; 43(3):2199-2209. PubMed ID: 34940128
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
[TBL] [Abstract][Full Text] [Related]
17. Function of the P2X7 receptor in hematopoiesis and leukemogenesis.
He X; Zhang Y; Xu Y; Xie L; Yu Z; Zheng J
Exp Hematol; 2021 Dec; 104():40-47. PubMed ID: 34687808
[TBL] [Abstract][Full Text] [Related]
18. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the functional properties of the P2X7 receptor for extracellular ATP.
Jiang LH; Caseley EA; Muench SP; Roger S
Purinergic Signal; 2021 Sep; 17(3):331-344. PubMed ID: 33987781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
